Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Ecuador | India | Malaysia
Approved Indications: None
Known Adverse Events: None
Company: Guangdong Lion Pharmaceutical Research Institute Co., Ltd. /Dalian Fusheng Natural Pharmaceutical Development Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Unknown Location
Active Clinical Trial Count: 1
Highest Development Phases
Phase 2: Common Cold|Headache|Influenza, Human
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| CTR20192482 | P2 |
Not yet recruiting |
Common Cold|Influenza, Human|Headache |
None |